Medical News

Effect of Mammographic Screening from Age 40 years on Breast...
Lancet Oncol

Yearly mammography before age 50 years, commencing at age 40 or 41 years, was associated with a relative reduction...

14 Aug 2020

Clinical characteristics of hyperprogressive disease in NSCL...
BMC Cancer

This study summarized the clinical features of HPD in NSCLC patients. The meta-analysis showed that five pre-...

31 Jul 2020

Albumin-bound paclitaxel and gemcitabine combination therapy...
BMC Cancer

Nab-paclitaxel/ gemcitabine combination chemotherapy is comparatively effective in the treatment of STS,...

30 Jul 2020

Association of Menopausal Hormone Therapy With Long-term Bre...
JAMA

In this long-term follow-up study of 2 randomized trials, prior randomized use of CEE alone, compared with placebo,...

29 Jul 2020

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Haematological Malignancies

Haematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. This slide set includes types, risk factors,...

 
Email this page

Key Trials

Improved Survival Outcomes with Androgen-Receptor-Axis-Targeted Therapies in Metastatic Castration-Sensitive Prostate Cancer

Androgen-receptor-axis-targeted (ARAT) agents improve the overall survival outcomes in patients with metastatic castration-sensitive prostate cancer...

OPTIMAL Trial: Erlotinib versus Chemotherapy as First-line Treatment for Patients with Advanced EGFR Mutation-positive Non-small-cell Lung Cancer

OPTIMAL is the first prospective head-to-head phase 3 study to examine the efficacy and safety of first-line erlotinib versus platinum doublet...

Clinical Safety and Oncologic Outcomes with GnRH Antagonists and Agonists in Metastatic Prostate Cancer

The GnRH antagonists were associated with lower risk of overall mortality, cardiovascular and musculoskeletal events as compared to agonists,...

AFFIRM Trial: Enzalutamide Significantly Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

The present study evaluated whether enzalutamide prolongs survival in men with castration-resistant prostate cancer after chemotherapy.  

Patient Education

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
44% (4 votes)
Tegafur uracil
0% (0 votes)
5-FU
56% (5 votes)
Total votes: 9